Literature DB >> 2951670

[Early diagnosis and surveillance of congenital toxoplasmosis. The comparative immunological profiles method].

J M Pinon, J Poirriez, B Leroux, D Dupouy, C Quereux, J P Garin.   

Abstract

More than 8000 samples (sera, cord blood, CSF, etc.) from patients who had, or were likely to have, toxoplasmosis were studied by the CIP-ELIFA technique. The first stage in this technique is immunoelectrodiffusion on a microporous cellulose acetate membrane. In the second stage, immunodetection and isotypic characterization of the precipitating systems are rapidly carried out by immunofiltration with anti-IgG, IgM, IgA or IgE-labelled antibodies (enzyme-linked immunofiltration assay or ELIFA). Several samples are jointly laid out on the same membrane for compared immunological profiles (CIP). When applied to the mother-foetus relationship in toxoplasmosis, this procedure provides an early diagnosis of congenital infestation in 85% of the cases. Positive criteria are based on evidence of specific IgM, IgE or IgA in the child, but also on the detection of foetal or neonatal antitoxoplasmosis IgG which can be distinguished from the IgG transmitted by the mother. Polyisotypic supervision is of considerable value for assessment of prognosis and of therapeutic effectiveness at the end of treatment. Satisfactory isotypic characterization can only be achieved by using particular functional antigens.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2951670

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  6 in total

1.  Onset of ocular complications in congenital toxoplasmosis associated with immunoglobulin M antibodies to Toxoplasma gondii.

Authors:  D Sibalić; O Djurković-Djaković; B Bobić
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-09       Impact factor: 3.267

2.  Early neonatal diagnosis of congenital toxoplasmosis: value of comparative enzyme-linked immunofiltration assay immunological profiles and anti-Toxoplasma gondii immunoglobulin M (IgM) or IgA immunocapture and implications for postnatal therapeutic strategies.

Authors:  J M Pinon; C Chemla; I Villena; F Foudrinier; D Aubert; D Puygauthier-Toubas; B Leroux; D Dupouy; C Quereux; M Talmud; T Trenque; G Potron; M Pluot; G Remy; A Bonhomme
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

3.  Detection of specific immunoglobulin E in patients with toxoplasmosis.

Authors:  J M Pinon; D Toubas; C Marx; G Mougeot; A Bonnin; A Bonhomme; M Villaume; F Foudrinier; H Lepan
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

4.  Multicenter evaluation of a new commercial assay for detection of immunoglobulin M antibodies to Toxoplasma gondii. Multicenter Study Group.

Authors:  V Luyasu; A R Robert; L Schaefer; J Macioszek
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-09       Impact factor: 3.267

5.  Diagnosis of congenital toxoplasmosis by immunoblotting and relationship with other methods.

Authors:  B F Chumpitazi; A Boussaid; H Pelloux; C Racinet; M Bost; A Goullier-Fleuret
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

6.  Evaluation of risk and diagnostic value of quantitative assays for anti-Toxoplasma gondii immunoglobulin A (IgA), IgE, and IgM and analytical study of specific IgG in immunodeficient patients.

Authors:  J M Pinon; F Foudrinier; G Mougeot; C Marx; D Aubert; O Toupance; G Niel; M Danis; P Camerlynck; G Remy
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.